Innate and Adaptive Immunity in Vaccination
A section of Vaccines (ISSN 2076-393X).
Editorial Board
Special Issues
Following special issues within this section are currently open for submissions:
- Immune Response and Vaccination Effectiveness against Mycobacterium tuberculosis Infection (Deadline: 30 September 2023)
- Analysis of Vaccine-Induced Adaptive Immune Responses (Deadline: 30 November 2023)
- SARS-CoV-2 Vaccination in Transplant Recipients (Deadline: 30 November 2023)
- Vaccination of Patients with Immune-Mediated Diseases (Deadline: 30 November 2023)
- Vaccine Immune Efficacy against Porcine Epidemic Diarrhea Virus (PEDV) (Deadline: 31 December 2023)
- Research in Innate and Adaptive Immunity (Deadline: 31 December 2023)
- Current Understanding of Immune Response after COVID-19 Vaccination (Deadline: 31 December 2023)
- Advances in Immunogenetics: From Genetics to Immune Responses (Deadline: 31 December 2023)
- Research on Immune Response and Vaccines (Deadline: 31 January 2024)
- Innate and Adaptive Immunity in HPV Pathogenesis and Treatment (Deadline: 29 February 2024)
- Neutrophils and Host Immunity (Deadline: 31 March 2024)
- The Immune Response in Patients after COVID-19 Vaccination (Deadline: 31 May 2024)
- Innate and Adaptive Immune Response against Human Herpesviruses (Deadline: 31 May 2024)
- Immunosenescence and Vaccine Immune Responses (Deadline: 31 May 2024)
- Immune Response after Vaccination in Patients with Inflammatory Diseases (Deadline: 30 June 2024)
